In the UK, IQVIA recently partnered with Integrated Care Systems (ICSs) and leaders in the Life Sciences sector to convene the 'Innovating to Address Health Inequalities Summit' in May of 2023. This event brought together groups from different sectors to work together to find new ways to overcome barriers and improve access to care for everyone.
More than 400 million people today live with rare diseases worldwide. IQVIA and Roche recently published a white paper that explores the rare disease funding environment and looks at ways to improve access to care for rare disease patients living in lower middle income countries.
There has been growing recognition of the importance of achieving representative diversity in clinical trials since the COVID-19 pandemic. A white paper produced by the IQVIA Institute looks at the scope of the problem and measures the progress made to date in increasing participation in clinical trials among underserved populations. This paper serves as a benchmark against which future progress can be measured.
IQVIA healthcare’s national language processing capabilities support clinicians and social workers in identifying patients in need using key social determinants of health. This effort was honored with the 2023 “Best AI-based Solution for Healthcare” in the AI-Breakthrough Awards competition hosted by a leading market intelligence organization. Learn more.
The value of patient experience data has been increasingly recognized. Yet many questions exist on how to get the best data and apply it in the best way. IQVIA has created an ebook exploring the topic and sharing insights from a variety of experts.
.svg){kind=icon}
